Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,807 | -2,671 | 779 | -6,042 | -5,036 |
| Depreciation Amortization | 133 | 109 | 93 | 241 | 200 |
| Accounts receivable | -183 | -156 | -7 | -371 | -281 |
| Other Working Capital | -429 | -290 | 204 | -2,444 | -1,534 |
| Other Operating Activity | -2,361 | -1,846 | -3,513 | -2,109 | -1,120 |
| Operating Cash Flow | $-6,647 | $-4,854 | $-2,444 | $-10,725 | $-7,771 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 6 | 6 | N/A | N/A | N/A |
| Other Investing Activity | 50 | 50 | 0 | 50 | 50 |
| Investing Cash Flow | $56 | $56 | $N/A | $50 | $50 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,500 | 4,500 | 4,500 | 4,988 | 4,988 |
| Other Financing Activity | -3,015 | -810 | -758 | -1,095 | -934 |
| Financing Cash Flow | $20,485 | $3,690 | $3,742 | $3,893 | $4,054 |
| Exchange Rate Effect | 14 | 13 | 46 | 108 | 17 |
| Beginning Cash Position | 7,838 | 7,838 | 7,838 | 14,512 | 14,512 |
| End Cash Position | 21,746 | 6,743 | 9,182 | 7,838 | 10,862 |
| Net Cash Flow | $13,908 | $-1,095 | $1,344 | $-6,674 | $-3,650 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,647 | -4,854 | -2,444 | -10,725 | -7,771 |
| Free Cash Flow | -6,647 | -4,854 | -2,444 | -10,725 | -7,771 |